Sastasundar Ventures Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2025
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures has published its unaudited financial results for the quarter ended June 30, 2025 in Business Standard (English) and Ek Din (Bengali) newspapers on August 13, 2025, as required by SEBI's Listing Regulations. On a standalone basis, the company reported total operating income of Rs 9.67 crore in Q1 FY26, up from Rs 8.19 crore a year ago, while posting a small loss of Rs 10.95 lakh versus a Rs 22.15 lakh loss in Q1 FY25 — the loss has narrowed meaningfully. On a consolidated basis, total income was Rs 298.43 crore (vs Rs 270.29 crore YoY), and net profit after tax came in at Rs 26.59 crore, lower than Rs 40.97 crore in Q1 FY25 but a strong recovery from Rs 17.57 crore in Q4 FY25. Standalone EPS stood at Rs (0.03) while consolidated EPS was Rs 7.52 for the quarter. The results were approved by the board on August 12, 2025 and signed by Chairman & MD Banwari Lal Mittal.
The consolidated business remains profitable with a sharp sequential rebound in earnings, though YoY profits have dipped. The standalone entity continues to make small losses, though the trend is improving. No new business trigger here — this is a routine regulatory disclosure of already-filed results, so share price reaction is likely limited.